Metraipolis › archive › dc_50ecd347d68d

Pragmatic health technology appraisals of biosimilars: a pilot case study of bevacizumab in colorectal cancer for NICE — Europe PMC PMID:42121166

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42121166
DOI
10.1186/s12962-[numero omesso]-w
License (as archived)
solo-consultazione
Archived
2026-11-02T10:21:44.417Z
SHA-256 of the archived text
e03d1523e9ce8bb2b68997096f76ea43f7bd5dc5a6a3ca66d8811410e533acff
Stable URL of this page
https://metraipolis.com/documento/dc_50ecd347d68d

How to cite

Pragmatic health technology appraisals of biosimilars: a pilot case study of bevacizumab in colorectal cancer for NICE — Europe PMC PMID:42121166 — Europe PMC (en), https://europepmc.org/article/MED/42121166 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_50ecd347d68d (Metraipolis archive dc_50ecd347d68d, sha256 e03d1523e9ce8bb2b68997096f76ea43f7bd5dc5a6a3ca66d8811410e533acff)
BibTeX
@misc{dc50ecd347d68d,
  title = {Pragmatic health technology appraisals of biosimilars: a pilot case study of bevacizumab in colorectal cancer for NICE — Europe PMC PMID:42121166},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42121166},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_50ecd347d68d; sha256 e03d1523e9ce8bb2b68997096f76ea43f7bd5dc5a6a3ca66d8811410e533acff},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42121166. Agents can read the archived copy with the MCP tool read_document.